Ebola vaccine R&D: Filling the knowledge gaps

Donata Medaglini, Ali M Harandi, Tom H M Ottenhoff, Claire-Anne Siegrist, VSV-Ebovac Consortium, Selidji Todagbe Agnandji, Raf Ahmed, Jenna Anderson, Floriane Auderset, Luisa Borgianni, Jessica Brosnahan, Annalisa Ciabattini, Olivier Engler, Marielle C Haks, Gray Heppner, Alice Gerlini, Peter Gottfried Kremsner, Stephen Leib, Thomas Monath, Francis Ndungu, Patricia Njuguna, Mark Page, Gianni Pozzi, Rino Rappuoli, Francesco Santoro, Marc Strasser, Donata Medaglini, Ali M Harandi, Tom H M Ottenhoff, Claire-Anne Siegrist, VSV-Ebovac Consortium, Selidji Todagbe Agnandji, Raf Ahmed, Jenna Anderson, Floriane Auderset, Luisa Borgianni, Jessica Brosnahan, Annalisa Ciabattini, Olivier Engler, Marielle C Haks, Gray Heppner, Alice Gerlini, Peter Gottfried Kremsner, Stephen Leib, Thomas Monath, Francis Ndungu, Patricia Njuguna, Mark Page, Gianni Pozzi, Rino Rappuoli, Francesco Santoro, Marc Strasser

Abstract

With an emphasis on systems analyses, the VSV-EBOVAC project harnesses state-of-the-art technologies that illuminate mechanisms behind the observed immunogenicity and reactogenicity of the rVSV-ZEBOV vaccine and ensures that such information is shared among stakeholders.

Trial registration: ClinicalTrials.gov NCT02283099 NCT02287480 NCT02296983.

Copyright © 2015, American Association for the Advancement of Science.

Figures

Fig. 1. Project plan form and functions.
Fig. 1. Project plan form and functions.
Shown in schematic form is the VSV-EBOVAC structure of the project plan. Blood samples and clinical data are obtained throughout the study, and clinical, immunological, and -omics data are integrated in order to identify molecular signatures associated with the rVSV-ZEBOV vaccine. The project is overseen by a management team consisting of the project coordinator, the scientific coordinator, and the work-package (WP) leaders. (Inset, right) The project is organized and carried out in four WPs. WP1 extends the clinical trials to 12 months and organizes sample distribution between partners.

Source: PubMed

3
Subskrybuj